Organ Retractor Device Study
Recruiting
- Conditions
- Liver Retraction During Bariatric Surgery
- Registration Number
- NCT06754514
- Lead Sponsor
- Boehringer Labs LLC
- Brief Summary
This study aims to assess the safety and efficacy of an organ retraction device. The study is low risk as it is only being used in patients already undergoing primary robotic bariatric surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- undergoing minimally invasive primary bariatric surgery
Exclusion Criteria
- known liver disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ease of use and Feasibility During surgery After surgery, surgeons will be asked a series of questions and asked to rank the ease of use on a scale of 1-10
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does the Boehringer organ retractor device compare to standard liver retraction techniques in robotic bariatric surgery outcomes?
What biomarkers correlate with reduced surgical trauma using the Boehringer retractor in NCT06754514?
What adverse event profiles are reported for organ retractor devices in bariatric surgery observational trials?
How does the Boehringer retractor's design influence intraoperative liver mobility and surgical precision metrics?
What alternative retractor systems or robotic-assisted techniques are evaluated for bariatric surgery in 2024-2025 trials?
Trial Locations
- Locations (1)
WakeMed Health & Hospitals
🇺🇸Raleigh, North Carolina, United States